/

Investors / Neovate Capital Partners

Neovate Capital Partners

Venture capital

neovate.vc

Neovate Capital Partners is an early-stage life sciences investment firm that invests in transformational medical devices and therapeutics. The firm draws on partners with operating and clinical experience in MedTech to support portfolio companies through strategy, commercial scaling, team building, financing, and exit planning.

Invests inHealthcare & Biotech

In its own wordslife sciencesmedical devicestherapeuticsmedtechroboticsneuromodulation

Your fit with Neovate Capital Partners

Three questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
16portfolio companies
3funding rounds on recordnamed lead in 0 of 2 that name one
3rounds, last 12 months
Seedmost frequent entryn=2 known entries

Neovate Capital Partners lists 16 companies on its own site. It is named in 3 funding rounds. Its most frequent entry is Seed, 50% of the 2 companies where the round it came in at is known. Its largest theme is Healthcare & Biotech (100%). 92% of its 12 companies with a known country are based in United States. It shares the most portfolio companies with Mountain State Capital, Connecticut Innovations and Creative Destruction Lab.

Counts come from funding rounds that name Neovate Capital Partners, complete from mid-2025: earlier rounds appear only when they were reported later. Reports often leave out co-leads, so a firm may have led more rounds than shown. Round amounts and full round histories are on Fundup AI.

Round figures show recent activity, not Neovate Capital Partners' whole history. Rounds on record name 3 companies; its own site lists 16. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.

Entry stage

share of companies by the stage it came in at · n=2

Counted only where the round is where it came in: a pre-seed or seed round, or a later round after the company raised without it.

Show as a table
Share of companies by the stage the firm came in at
Value
Pre-seed0%
Seed50%
Series A50%
Series B0%
Growth0%

Activity by year

rounds it joined, last 10 years
Show as a table
Funding rounds per year
TotalRounds it led
'1700
'1800
'1900
'2000
'2100
'2200
'2300
'2400
'2500
'2630

Investor profile

percentile among all firms
Portfolio size: 16 companiesRecent activity: 3 rounds in 12 monthsEarly stage: 50% of 2 known entries at pre-seed or seedEvidence: 6% of companies confirmed by a roundSector focus: 100% of companies in its largest themeReach: 2 countries, from 12 companies with a known countryPortfolio size39th pctRecent activity71st pctEarly stage13th pctEvidence65th pctSector focus98th pctReach32nd pct
This firmMedian of all firms
Show as a table
Neovate Capital Partners compared with all firms
MeasurePercentile of all firmsValue
Portfolio size39th16 companies
Recent activity71st3 rounds in 12 months
Early stage13th50% of 2 known entries at pre-seed or seed
Evidence65th6% of companies confirmed by a round
Sector focus98th100% of companies in its largest theme
Reach32nd2 countries, from 12 companies with a known country

Shares portfolio companies with

firms that back the same companies, not always in the same round
Show as a table
Co-investors
Share
Mountain State Capital6
Connecticut Innovations2
Creative Destruction Lab2
Gaingels2
AAF Management1
AMR Action Fund1
Accanto Partners1
Asimov Ventures1

All co-investors

Its portfolio companies

where they are based, and what their own sites show

Headquarters

Site status

  • Site answers16100%
  • No longer answers00%
  • Points to another company00%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Investment themes

share of its 16 companies with a theme; a company can have two

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
Healthcare & Biotech100%17%

Compare Neovate Capital Partners head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Team

1 person, as Neovate Capital Partners' own site lists them
  • Nick Pachuda D.P.M.Partner

Names and roles from this page of its site; VCinfo keeps nothing else about them. Listed here and want to be removed? Write to us.

Recent portfolio activity

when companies last raised with Neovate Capital Partners
DateCompanyStage
3 Nov 2026OSSTECosstec.ukSeed
21 Jul 2026Tybr Healthtybrhealth.comSeries A
18 Jun 2026Icarus Medicalicarusmedical.comSeries A

Round details for Neovate Capital Partners

Amounts, full round histories and every co-investor in Neovate Capital Partners' rounds are on Fundup AI. VCinfo covers investors and their portfolios.

See rounds on Fundup AI →

Portfolio

16 companies checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
Avisi Technologies, Inc.avisitech.com · United StatesAvisi Technologies develops a nanotechnology-enabled device to treat open-angle glaucoma
Healthcare & Biotech
Portfolio page
Cairacairasurgical.com · United StatesCaira is inventing advanced joint replacement software, scanning, and precision radar technologies
Healthcare & Biotech
Portfolio page
DiscGenics, Inc.discgenics.comDiscGenics develops regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.
Healthcare & Biotech
Portfolio page
Discurediscuremd.comDiscure develops and tests a minimally invasive, implantable device to treat degenerative disc disease and restore function to the spine
Healthcare & Biotech
Portfolio page
Icarus Medicalicarusmedical.com · United StatesIcarus Medical provides braces for a wide range of use cases and applications
Healthcare & Biotech
Jun 2026Series AFunding round
Nanochonnanochon.com · United StatesNanochon designs and develops 3D-printed implants to help repair cartilage naturally
Healthcare & Biotech
Portfolio page
Ocugenixocugenix.comOcugenix develops therapies for eye diseases such as wet macular degeneration, geographic atrophy, and diabetic retinopathy
Healthcare & Biotech
Portfolio page
OSSTECosstec.uk · United KingdomOSSTEC develops and provides biomimetic cementless fixation technology for joint replacement surgery
Healthcare & Biotech
Nov 2026SeedFunding round
Ostealostealtx.com · United StatesOsteal Therapeutics is a musculoskeletal therapeutics company developing medications for the treatment of orthopedic infections and their consequences.
Healthcare & Biotech
Portfolio page
Peca Labspecalabs.com · United StatesPeca Labs develops and manufactures vascular grafts and heart valves using polymeric materials.
Healthcare & Biotech
Portfolio page
Peptilogicspeptilogics.com · United StatesPeptilogics is a surgical therapeutics company that develops a novel anti-biofilm drug to cure and prevent medical device-related infections.
Healthcare & Biotech
Portfolio page
Phoenix Kineticsphoenixkinetics.comPhoenix Kinetics is a company that develops medical implants, specifically the NUsurface Implant, for knee preservation and treatment of early knee osteoarthritis.
Healthcare & Biotech
Portfolio page
Restor3drestor3d.com · United StatesThe company creates personalized, 3D-printed orthopedic implants for patients.
Healthcare & Biotech
Portfolio page
RevMedicarevmedica.com · United StatesRevMedica develops a surgical stapling platform that provides real-time tissue data to surgeons
Healthcare & Biotech
Portfolio page
Tybr Healthtybrhealth.com · United StatesTybr Health develops and sells a gel system for improving post-operative tendon mobility
Healthcare & Biotech
Jul 2026Series APage + round
Veradermicsveradermics.com · United StatesVeradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company developing innovative therapeutics for pattern hair loss.
Healthcare & Biotech
Portfolio page

About this data

site last read 17 Nov 2026
The homepage of Neovate Capital Partners, as last read
neovate.vc as VCinfo last read it
Site
neovate.vc
Last read
17 Nov 2026
Watching since
17 Nov 2026
Rounds since
18 Jun 2026
Companies checked
16

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get Neovate Capital Partners' profile as data

Pull Neovate Capital Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/neovate.vc

# also
GET /v1/firms/neovate.vc/portfolio
GET /v1/firms/neovate.vc/coinvestors
GET /v1/firms/neovate.vc/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing